Search

Your search keyword '"Mcguffog, L"' showing total 472 results

Search Constraints

Start Over You searched for: Author "Mcguffog, L" Remove constraint Author: "Mcguffog, L"
472 results on '"Mcguffog, L"'

Search Results

1. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

2. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

3. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

4. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

5. Polygenic risk modeling for prediction of epithelial ovarian cancer risk (vol 30, pg 349, 2021)

6. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

7. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

8. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

9. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

10. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

11. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

12. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

13. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

14. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

15. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

16. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

17. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

18. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.

19. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

20. Characterization of the Cancer Spectrum in Men with Germline BRCA1 and BRCA2 Pathogenic Variants: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

21. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.

22. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

23. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (vol 12, 1078, 2021)

24. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

25. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

26. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

27. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

28. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

29. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

30. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

31. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

32. Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness.

33. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

34. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

35. Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer.

36. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

37. Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer

38. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

39. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

40. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

41. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

42. Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer

43. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

45. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

46. A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk

47. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

48. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

49. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

50. Shared heritability and functional enrichment across six solid cancers.

Catalog

Books, media, physical & digital resources